Camilla Hage

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ESC HEART FAILURE. 2024;11(5):2661-2671
Iron deficiency in new onset heart failure: association with clinical factors and quality of life
Cabrera CC; Ekstrom M; Tornvall P; Lofstrom U; Frisk C; Linde C; Hage C; Persson H; Eriksson MJ; Wallen H; Persson B; Lynga P
Article: ESC HEART FAILURE. 2024
Rates and predictors of cardiovascular and non-cardiovascular outcomes in heart failure with preserved ejection fraction
Shahim A; Donal E; Hage C; Oger E; Savarese G; Persson H; Haugen-Loefman I; Ennezat P-V; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C; Lund LH
Article: AMERICAN HEART JOURNAL. 2024;271:136-147
Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT
Szabo B; Benson L; Savarese G; Hage C; Fudim M; Devore A; Pitt B; Lund LH
Article: SCIENTIFIC REPORTS. 2024;14(1):5811
Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure
Frisk C; Das S; Eriksson MJ; Walentinsson A; Corbascio M; Hage C; Kumar C; Ekstroem M; Maret E; Persson H; Linde C; Persson B
Article: LANCET GLOBAL HEALTH. 2024;12(3):e396-e405
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry
Walli-Attaei M; Joseph P; Johansson I; Sliwa K; Lonn E; Maggioni AP; Mielniczuk L; Ross H; Karaye K; Hage C; Pogosova N; Grinvalds A; Mccready T; Mcmurray J; Yusuf S
Article: ESC HEART FAILURE. 2024;11(1):601-605
Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure
Erhardsson M; Faxen UL; Venkateshvaran A; Hage C; Pironti G; Thorvaldsen T; Webb D-L; Hellstroem PM; Andersson DC; Stahlberg M; Lund LH
Article: EUROPEAN HEART JOURNAL: DIGITAL HEALTH. 2024;5(1):60-68
External validation of a deep learning algorithm for automated echocardiographic strain measurements
Myhre PL; Hung C-L; Frost MJ; Jiang Z; Ouwerkerk W; Teramoto K; Svedlund S; Saraste A; Hage C; Tan R-S; Beussink-Nelson L; Fermer ML; Gan L-M; Hummel YM; Lund LH; Shah SJ; Lam CSP; Tromp J
Article: PLOS ONE. 2024;19(5):e0303348
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry
Lindberg F; Oigaard N; Metra M; Rosano GMC; Dahlstrom U; Mol P; Hage C; Lund LH; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(12):2164-2173
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: data from Swedish Heart Failure Registry
Guidetti F; Lund LH; Benson L; Hage C; Musella F; Stolfo D; Mol PGM; Flammer AJ; Ruschitzka F; Dahlstrom U; Rosano GMC; Braun OO; Savarese G
Article: ESC HEART FAILURE. 2023;10(6):3729-3734
Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
Erhardsson M; Faxen UL; Venkateshvaran A; Svedlund S; Saraste A; Fermer ML; Gan L-M; Shah SJ; Tromp J; Lam CSP; Lund LH; Hage C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(11):1962-1975
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF model
Burger PM; Savarese G; Tromp J; Adamson C; Jhund PS; Benson L; Hage C; Tay WT; Solomon SD; Packer M; Rossello X; McEvoy JW; De Bacquer D; Timmis A; Vardos P; Graham LM; Di Angelantonio E; Visseren FLJ; McMurray JJV; Lam CSP; Lund LH; Koudstaal S; Dorresteijn JAN; Mosterd A
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(9):1571-1583
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry
Kaplon-Cieslicka A; Benson L; Chioncel OG; Crespo-Leiro M; Coats AJSD; Anker S; Ruschitzka F; Hage C; Drozdz J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Mullens W; Bayes-Genis AP; Maggioni AH; Lund L
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(8):1246-1253
Patient profiles in heart failure with reduced ejection fraction: Prevalence, characteristics, treatments and outcomes in a real-world heart failure population
Musella F; Rosano GMC; Hage C; Benson L; Guidetti F; Moura B; Sibilio G; Boccalatte M; Dahlstrom U; Coats AJS; Lund LH; Savarese G
Article: JACC-HEART FAILURE. 2023;11(7):775-787
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
Michaelsson E; Lund LH; Hage C; Shah SJ; Voors AA; Saraste A; Redfors B; Grove EL; Barasa A; Richards M; Svedlund S; Lagerstroem-Fermer M; Gabrielsen A; Garkaviy P; Gan L-M; Lam CSP
Article: EUROPEAN HEART JOURNAL. 2023;44(22):2009-2025
Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization
Lund LH; Hage C; Pironti G; Thorvaldsen T; Ljung-Faxen U; Zabarovskaja S; Shahgaldi K; Webb D-L; Hellstrom PM; Andersson DC; Stahlberg M
Article: ESC HEART FAILURE. 2023;10(3):1835-1846
Long-term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non-cardiac mortality
Shahim A; Hourqueig M; Lund LH; Savarese G; Oger E; Venkateshvaran A; Benson L; Daubert J-C; Linde C; Donal E; Hage C
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023;329(19):1650-1661
Global Variations in Heart Failure Etiology, Management, and Outcomes
Joseph P; Roy A; Lonn E; Stoerk S; Floras J; Mielniczuk L; Rouleau J-L; Zhu J; Dzudie A; Balasubramanian K; Karaye K; AlHabib KF; Gomez-Mesa JE; Branch KR; Makubi A; Budaj A; Avezum A; Wittlinger T; Ertl G; Mondo C; Pogosova N; Maggioni AP; Orlandini A; Parkhomenko A; ElSayed A; Lopez-Jaramillo P; Grinvalds A; Temizhan A; Hage C; Lund LH; Kazmi K; Lanas F; Sharma SK; Fox K; McMurray JJV; Leong D; Dokainish H; Khetan A; Yonga G; Kragholm K; Shaker KW; Mwita JC; Al Mulla AA; Alla F; Damasceno A; Silva-Cardoso J; Dans AL; Sliwa K; O'Donnell M; Bazargani N; Bayes-Genis A; McCready T; Probstfield J; Yusuf S
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;379:82-88
Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle
Cabrera C; Frisk C; Lofstrom U; Lynga P; Linde C; Hage C; Persson H; Eriksson MJ; Wallen H; Persson B; Ekstrom M
Article: AMERICAN HEART JOURNAL. 2023;259:42-51
Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction
Faxen J; Benson L; Mantel A; Savarese G; Hage C; Dahlstrom U; Askling J; Lun LH; Andersson DC
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(12):2251-2260
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study
Venkateshvaran A; Faxen UL; Hage C; Michaelsson E; Svedlund S; Saraste A; Beussink-Nelson L; Fermer ML; Gan L-M; Tromp J; Lam CSP; Shah SJ; Lund LH
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022;11(22):e026708
Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
Stolfo D; Lund LH; Benson L; Hage C; Sinagra G; Dahlstrom U; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(11):2066-2077
Association between heart failure quality of care and mortality: a population-based cohort study using nationwide registries
Batra G; Aktaa S; Benson L; Dahlstrom U; Hage C; Savarese G; Vasko P; Gale CP; Lund LH
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2022;556:111738
Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities
Pedersen AKN; Hage C; Jessen N; Mellbin L; Bjerre M
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(9):1478-1490
Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme
Johansson I; Balasubramanian K; Bangdiwala S; Mielniczuk L; Hage C; Sharma SK; Branch K; Zhu J; Kragholm K; Sliwa K; Alla F; Yonga G; Roy A; Orlandini A; Grinvalds A; McCready T; Pogosova N; Stoerk S; McMurray JJV; Conen D; Yusuf S
Article: ESC HEART FAILURE. 2022;9(4):2125-2138
Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study
Linde C; Ekstrom M; Eriksson MJ; Maret E; Wallen H; Lynga P; Weden U; Cabrera C; Lofstrom U; Stenudd J; Lund LH; Persson B; Persson H; Hage C
Article: ESC HEART FAILURE. 2022;9(4):2107-2118
Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction
Savarese G; Uijl A; Ouwerkerk W; Tromp J; Anker SD; Dickstein K; Hage C; Lam CSP; Lang CC; Metra M; Ng LL; Orsini N; Samani NJ; Veldhuisen DJ; Cleland JGF; Voors AA; Lund LH
Article: JACC-HEART FAILURE. 2022;10(6):380-392
Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry
Jackson AM; Benson L; Savarese G; Hage C; Jhund PS; Petrie MC; Dahlstrom U; McMurray JJV; Lund LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(6):1047-1062
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata
Stolfo D; Lund LH; Becher PM; Orsini N; Thorvaldsen T; Benson L; Hage C; Dahlstrom U; Sinagra G; Savarese G
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(4):681-684
Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction
Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan R-S; Beussink-Nelson L; Fermer ML; Gan L-M; Lund L; Shah SJ; Lam CSP
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2022;24(2):335-350
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry
Kaplon-Cieslicka A; Benson L; Chioncel O; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Ruschitzka F; Hage C; Drozdz J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Maggioni AP; Lund LH
Article: ESC HEART FAILURE. 2022;9(1):164-177
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial
Lund LH; Savarese G; Venkateshvaran A; Benson L; Lundberg A; Donal E; Daubert J-C; Oger E; Linde C; Hage C
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2022;9:952974
Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
Matan D; Mobarrez F; Lofstrom U; Corbascio M; Ekstrom M; Hage C; Lynga P; Persson B; Eriksson M; Linde C; Persson H; Wallen H
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2021;343:63-72
Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry
Kapelios CJ; Canepa M; Benson L; Hage C; Thorvaldsen T; Dahlstrom U; Savarese G; Lund LH
Article: ESC HEART FAILURE. 2021;8(5):4243-4254
Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen study
Shahim A; Hourqueig M; Donal E; Oger E; Venkateshvaran A; Daubert J-C; Savarese G; Linde C; Lund LH; Hage C
Article: JOURNAL OF CARDIAC FAILURE. 2021;27(7):756-765
Generalizability of HFA-PEFF and H₂FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF
Faxen UL; Venkateshvaran A; Shah SJ; Lam CSP; Svedlund S; Saraste A; Beussink-Nelson L; Fermer ML; Gan L-M; Hage C; Lund LH
Article: JOURNAL OF CARDIAC FAILURE. 2021;27(3):277-285
The Differential Impact of the Left Atrial Pressure Components on Pulmonary Arterial Compliance-Resistance Relationship in Heart Failure
Najjar E; Lund LH; Hage C; Nagy AI; Johnson J; Manouras A
Article: JOURNAL OF INTERNAL MEDICINE. 2021;289(3):369-384
Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry
Savarese G; Hage C; Benson L; Schrage B; Thorvaldsen T; Lundberg A; Fudim M; Linde C; Dahlstrom U; Rosano GMC; Lund LH
Article: DIABETES-METABOLISM RESEARCH AND REVIEWS. 2021;37(3):e3385
Effect of dipeptidyl peptidase-4 inhibitors on complement activation
Hoffmann-Petersen IT; Holt CB; Jensen L; Hage C; Mellbin LG; Thiel S; Hansen TK; Ostergaard JA
Article: SCIENTIFIC REPORTS. 2021;11(1):4885
Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
Patel RB; Lam CSP; Svedlund S; Saraste A; Hage C; Tan R-S; Beussink-Nelson L; Tromp J; Sanchez C; Njoroge J; Swat SA; Faxen UL; Fermer ML; Venkateshvaran A; Gan L-M; Lund LH; Shah SJ
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2021;55(1):1-8
Reorganization of heart failure management and improved outcome - the 4D HF Project
Matan D; Lofstrom U; Cabrera CC; Eriksson B; Ekstrom M; Hage C; Ljunggren G; Lynga P; Wallen H; Malmqvist KK; Linde C; Persson H
Article: JOURNAL OF CARDIAC FAILURE. 2020;26(12):1050-1059
Metabolomic Profile in HFpEF vs HFrEF Patients
Hage C; Lofgren L; Michopoulos F; Nilsson R; Davidsson P; Kumar C; Ekstrom M; Eriksson MJ; Lynga P; Persson B; Wallen H; Gan LM; Persson H; Linde C
Article: CIRCULATION. 2020;142(21):2029-2044
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Results From the PROMIS-HFpEF Study
Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan R-S; Fermer ML; Gan L-M; Lund LH; Lam CSP; Shah SJ
Article: CIRCULATION RESEARCH. 2020;127(10):1261-1273
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD
Hussain S; Khan AW; Akhmedov A; Suades R; Costantino S; Paneni F; Caidahl K; Mohammed SA; Hage C; Gkolfos C; Bjorck H; Pernow J; Lund LH; Luscher TF; Cosentino F
Article: ESC HEART FAILURE. 2020;7(5):2098-2112
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
Kaplon-Cieslicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padron A; Fucili A; Drozdz J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH
Article: AMERICAN HEART JOURNAL. 2020;227:56-63
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry
Joseph P; Dokainish H; McCready T; Budaj A; Roy A; Ertl G; Gomez-Mesa JE; Leong D; Ezekowitz J; Hage C; Lanas F; Maggioni AP; Sliwa K; Zhu J; Rouleau J; Balasubramanian K; Yusuf S
Article: ESC HEART FAILURE. 2020;7(4):1534-1546
Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients
Hage C; Michaelsson E; Kull B; Miliotis T; Svedlund S; Linde C; Donal E; Daubert J-C; Gan L-M; Lund LH
Article: JOURNAL OF CARDIAC FAILURE. 2020;26(8):673-684
Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria
Hage C; Lofstrom U; Donal E; Oger E; Kaplon-Cieslicka A; Daubert J-C; Linde C; Lund LH
Article: ARCHIVES OF CARDIOVASCULAR DISEASES. 2020;113(6-7):381-390
Heart failure with preserved ejection fraction: A clustering approach to a heterogenous syndrome
Schrub F; Oger E; Bidaut A; Hage C; Charton M; Daubert JC; Leclercq C; Linde C; Lund L; Donal E
Article: ESC HEART FAILURE. 2020;7(2):737-746
The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
Ekstrom M; Hellman A; Hasselstrom J; Hage C; Kahan T; Ugander M; Wallen H; Persson H; Linde C
Article: ESC HEART FAILURE. 2020;7(2):445-455
Circulating neuregulin1-β in heart failure with preserved and reduced left ventricular ejection fraction
Hage C; Wardell E; Linde C; Donal E; Lam CSP; Daubert C; Lund LH; Mansson-Broberg A
Article: HEART. 2020;106(5):342-349
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Hedman AK; Hage C; Sharma A; Brosnan MJ; Buckbinder L; Gan L-M; Shah SJ; Linde CM; Donal E; Daubert J-C; Malarstig A; Ziemek D; Lund L
Article: ESC HEART FAILURE. 2019;6(4):830-839
Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
Lofstrom U; Hage C; Savarese G; Donal E; Daubert J-C; Lund LH; Linde C
Article: CLINICAL RESEARCH IN CARDIOLOGY. 2019;108(6):703-715
Left atrial strain improves estimation of filling pressures in heart failure: a simultaneous echocardiographic and invasive haemodynamic study
Lundberg A; Johnson J; Hage C; Baeck M; Merkely B; Venkateshvaran A; Lund LH; Nagy AI; Manouras A
Article: SCIENTIFIC REPORTS. 2019;9(1):3179
Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction
Das S; Frisk C; Eriksson MJ; Walentinsson A; Corbascio M; Hage C; Kumar C; Asp M; Lundeberg J; Maret E; Persson H; Linde C; Persson B
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2019;53(1):21-27
ST2 in heart failure with preserved and reduced ejection fraction
Najjar E; Faxen UL; Hage C; Donal E; Daubert J-C; Linde C; Lund LH
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;274:202-207
Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study
Persson H; Donal E; Lund LH; Matan D; Oger E; Hage C; Daubert J-C; Linde C
Article: EUROPEAN HEART JOURNAL. 2018;39(37):3439-3450
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan R-S; Beussink-Nelson L; Faxen UL; Fermer ML; Broberg MA; Gan L-M; Lund LH
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;267:128-132
Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome
Faxen UL; Hage C; Donal E; Daubert J-C; Linde C; Lund LH
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2018;121(12):1558-1566
Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert J-C; Linde C; Lund LH
Article: JOURNAL OF CARDIAC FAILURE. 2018;24(6):365-374
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction
Savarese G; Orsini N; Hage C; Dahlstrom U; Vedin O; Rosano GMC; Lund LH
Article: ESC HEART FAILURE. 2018;5(3):302-308
Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
Najjar E; Stalhberg M; Hage C; Ottenblad E; Manouras A; Lofman IH; Lund LH
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(4):380-391
Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction
Nagy AI; Hage C; Merkely B; Donal E; Daubert J-C; Linde C; Lund LH; Manouras A
Article: JACC-HEART FAILURE. 2018;6(3):246-256
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
Savarese G; Orsini N; Hage C; Vedin O; Cosentino F; Rosano GMC; Dahlstrom U; Lund LH
Article: HEART AND VESSELS. 2017;32(6):735-749
The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study
Bosseau C; Donal E; Lund LH; Oger E; Hage C; Mulak G; Daubert J-C; Linde C
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2017;18(6):629-635
Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction
Donal E; Lund LH; Oger E; Bosseau C; Reynaud A; Hage C; Drouet E; Daubert J-C; Linde C
Article: JOURNAL OF CARDIAC FAILURE. 2017;23(4):293-303
HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1
Faxen UL; Hage C; Benson L; Zabarovskaja S; Andreasson A; Donal E; Daubert J-C; Linde C; Brismar K; Lund LH
Article: HEART LUNG AND CIRCULATION. 2017;26(2):143-149
Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation
Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;228:709-716
HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin
Faxen UL; Hage C; Andreasson A; Donal E; Daubert J-C; Linde C; Brismar K; Lund LH
Article: CIRCULATION-GENOMIC AND PRECISION MEDICINE. 2017;10(1):e001633
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
Hage C; Michaelsson E; Linde C; Donal E; Daubert J-C; Gan L-M; Lund LH
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;226:65-70
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study
Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert J-C; Linde C; Lund LH
Article: CIRCULATION-HEART FAILURE. 2016;9(11):e003105
Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction
Savarese G; Hage C; Orsini N; Dahlstrom U; Perrone-Filardi P; Rosano GMC; Lund LH
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;220:750-758
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)
Makubi A; Hage C; Sartipy U; Lwakatare J; Janabi M; Kisenge P; Dahlstrom U; Ryden L; Makani J; Lund LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18(10):1287-1297
Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants
Linde C; Eriksson MJ; Hage C; Wallen H; Persson B; Corbascio M; Lundeberg J; Maret E; Ugander M; Persson H
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2016;13(4):307-311
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study
Arnetz L; Hage C; Brismar K; Catrina S-B; Norhammar A; Lundman P; Wallander M; Ryden L; Mellbin L
Article: GROWTH HORMONE & IGF RESEARCH. 2015;25(6):298-303
Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity
Arnetz L; Hage C; Ekberg NR; Alvarsson M; Brismar K; Norhammar A; Mellbin L
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;199:415-423
Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction
Savarese G; Edner M; Dahlstrom U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2015;17(10):755-758
Accuracy of a Simplified Glucose Measurement Device-The HemoCue Glucose 201RT
Segerhag E; Gyberg V; Ioannides K; Jennings C; Ryden L; Stagmo M; Hage C
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(7):680-688
New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat P-V; Bauer F; Drouet E; Linde C; Daubert C
Article: HEART. 2015;101(8):592-599
Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure
Makubi A; Hage C; Lwakatare J; Mmbando B; Kisenge P; Lund LH; Ryden L; Makani J
Article: OPEN HEART. 2015;2(1):e000260
Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.
Hage C; Lund LH; Donal E; Daubert J-C; Linde C; Mellbin L
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;189:6-11
Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes
Zabarovskaja S; Hage C; Linde C; Daubert J-C; Donal E; Gabrielsen A; Mellbin L; Lunda LH
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(9):992-1001
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction
Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Lofman I; Ennezat P-V; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C
Article: HEART. 2014;100(16):1235-1241
Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study
Makubi A; Hage C; Lwakatare J; Kisenge P; Makani J; Ryden L; Lund LH
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2014;11(4):290-293
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI study
Hage C; Brismar K; Lundman P; Norhammar A; Ryden L; Mellbin L
Article: ARCHIVES OF CARDIOVASCULAR DISEASES. 2014;107(2):112-121
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat P-V; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert J-C; Linde C
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2013;20(4):549-554
Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes
Hage C; Lundman P; Ryden L; Mellbin L
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(4):410-421
Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities-the BEGAMI study
Hage C; Brismar K; Efendic S; Lundman P; Ryden L; Mellbin L
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2011;8(2):143-149
The predictive value of inflammatory activity and markers of the adipo-insular axis on restenosis in patients with type 2 diabetes
Hage C; Grip L; Malmberg K; Ryden L; Wallander M; Saleh N
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2010;12(4):291-295
Glucose Monitoring by Means of an Intravenous Microdialysis Catheter Technique
Hage C; Mellbin L; Ryden L; Wernerman J
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2009;6(2):71-79
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study
Hage C; Norhammar A; Grip L; Malmberg K; Sarkar N; Svane B; Ryden L
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(2):198-204
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction
Donal E; Lund LH; Linde C; Edner M; Lafitte S; Persson H; Bauer F; Ohrvik J; Ennezat P-V; Hage C; Loefman I; Juilliere Y; Logeart D; Derumeaux G; Gueret P; Daubert J-C
Article: PHYSIOTHERAPY RESEARCH INTERNATIONAL. 2003;8(1):13-22
Long-term effects of exercise training on physical activity level and quality of life in elderly coronary patients--a three- to six-year follow-up.
Hage C; Mattsson E; Ståhle A
Visa fler

Alla övriga publikationer

Editorial comment: LANCET. 2024;404(10456):909-911
GLP-1 receptor agonists in heart failure: how farto expand use?
Hage C
Editorial comment: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024;83(18):1740-1742
More Evidence That HF With Normal EF Is Distinct From HF Below Normal EF
Hage C; Sundstrom J; Lund LH
Editorial comment: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2024;401:131834
Inflammation and myeloperoxidase - The next treatment targets in heart failure?
Hage C; Lund LH
Letter: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(11):2093-2095
Acyl ghrelin infusion increases circulating growth hormone in patients with heart failure and reduced ejection fraction
Hage C; Stahlberg M; Thorvaldsen T; Faxen UL; Pironti G; Webb D-L; Hellstrom PM; Andersson DC; Lund LH
Editorial comment: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25(11):2091-2092
Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease - No heterogeneity
Hage C; Lund LH
Editorial comment: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2023;30(7):581-582
Proteomic profiling for investigating the pathophysiology of myocardial infarction
Hage C; Savarese G
Editorial comment: EUROPEAN HEART JOURNAL. 2022;43(5):413-415
Implementation science and potential for screening in heart failure
Lund LH; Hage C; Savarese G
Editorial comment: JOURNAL OF CARDIAC FAILURE. 2020;26(11):1016-1021
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study
Hage C; Svedlund S; Saraste A; Faxen UL; Benson L; Fermer ML; Gan L-M; Shah SJ; Lam CSP; Lund LH
Editorial comment: JOURNAL OF CARDIAC FAILURE. 2020;26(5):440-443
Increased iron absorption in patients with chronic heart failure and iron deficiency
Cabrera CC; Ekstrom M; Linde C; Persson H; Hage C; Eriksson MJ; Wallen H; Persson B; Tornvall P; Lynga P
Letter: CIRCULATION. 2019;140(16):1359-1361
Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Tromp J; Hage C; Ouwerkerk W; Sanders-van Wijk S; Svedlund S; Saraste A; Ljung Faxen U; Lagerstrom Fermer M; Gan L-M; Lund LH; Shah SJ; Lam CSP
Corrigendum: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;261:240
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study (vol 226, pg 65, 2017)
Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert J-C; Linde C; Lund LH
Thesis / dissertation: 2012
Glucose-lowering interventions and risk assessment in patients with coronary heart disease and disturbed glucose metabolism
Hage, Camilla
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2010;145(2):259-260
The impact of infarct type on the reliability of early oral glucose tolerance testing in patients with myocardial infarction
Hage C; Malmberg K; Ryden L; Wallander M

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2012

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI